Showing results (41-50 of 116) with videos related to
Sort By:
Pageof 12
Cancer Research|March 1, 1987
Gangliosides of human melanoma: altered expression in vivo and in vitroT Tsuchida, M H Ravindranath, R E Saxton, et al.Cancer|June 15, 1991
Ganglioside GM3:GD3 ratio as an index for the management of melanomaM H Ravindranath, T Tsuchida, D L Morton, et al.Cancer Immunology, Immunotherapy : CII|October 18, 2003
Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanomaReiko F Irie, David W Ollila, Steven O'Day, et al.The Journal of Cell Biology|October 6, 2000
Synbindin, A novel syndecan-2-binding protein in neuronal dendritic spinesI M Ethell, K Hagihara, Y Miura, et al.Cellular Immunology|June 15, 1997
Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patientsT Takahashi, R F Irie, D L Morton, et al.The American Journal of Pathology|June 17, 1998
Cellular immuno-PCR. Detection of a carbohydrate tumor markerZ Zhang, R F Irie, D D Chi, et al.Cancer Immunology, Immunotherapy : CII|October 1, 1993
A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin AN Morioka, L L Sze, D L Morton, et al.Journal of the National Cancer Institute|January 1, 1987
Gangliosides of human melanomaT Tsuchida, R E Saxton, D L Morton, et al.Journal of Clinical & Laboratory Immunology|November 1, 1980
Natural humoral immunity in patients with malignant diseaseM Higuchi, R K Gupta, R F Irie, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 1983
Ganglioside GM2 as a human tumor antigen (OFA-I-1)T Tai, J C Paulson, L D Cahan, et al.Pageof 12